DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical items. The $3,036.09 order has a completion date of December 2023 and was awarded on November 29, 2023 without a set-aside designation. DMS Pharmaceutical Group will fulfill the order from its place of performance in Park Ridge, Illinois as a woman-owned small business and woman-owned entity. The underlying indefinite delivery contract held by DMS Pharmaceutical Group has a potential value of up to $5 million to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolam hydrochloride and other medical supplies to military treatment facilities supported by the Defense Logistics Agency through December 2025.
Generated 2/28/24, 10:10 AM